Among them, SFN was found to be upregulated in both GSE14814 and GSE42127 datasets and was also found to significantly upregulate in recurrent NSCLC patient tissue when compared in para-tumor normal tissue and primary cancer tissue. This evidence concerns the gene SFN and cancer.